Literature DB >> 24809393

Neurotrophic factors for retinal ganglion cell neuropathy - with a special reference to diabetic neuropathy in the retina.

Guzel Bikbova, Toshiyuki Oshitari, Takayuki Baba, Shuichi Yamamoto1.   

Abstract

Diabetes mellitus is a disease with a devastating impact on population. Recent data revealed that early retinal neuropathy in patients with diabetic retinopathy involved a reduced expression of brain-derived neurotrophic factor. Retinal ganglion cells (RGC) neuropathy is a progressive optic nerve neuropathy with RGC death and axonal degeneration, and it leads to blindness in the elderly population worldwide. Thus, neuroprotective therapies that rescue damaged RGCs and inhibit the progression of RGC loss and axonal degeneration are needed. This review introduces potential neuroprotective therapies using different neurotrophic factors for damaged RGC in eyes with RGC neuropathy associated diseases.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24809393     DOI: 10.2174/1573399810666140508121927

Source DB:  PubMed          Journal:  Curr Diabetes Rev        ISSN: 1573-3998


  14 in total

1.  Retinal and circulating miRNA expression patterns in diabetic retinopathy: An in silico and in vivo approach.

Authors:  Chiara Bianca Maria Platania; Rosa Maisto; Maria Consiglia Trotta; Michele D'Amico; Settimio Rossi; Carlo Gesualdo; Giovanbattista D'Amico; Cornel Balta; Hildegard Herman; Anca Hermenean; Franca Ferraraccio; Iacopo Panarese; Filippo Drago; Claudio Bucolo
Journal:  Br J Pharmacol       Date:  2019-05-09       Impact factor: 8.739

2.  Differential Expression of BDNF and BIM in Streptozotocin-induced Diabetic Rat Retina After Fluoxetine Injection.

Authors:  Seong Taeck Kim; Yoon Young Chung; Hyo-In Hwang; Hye-Kyoung Shin; Ranju Choi; Yong Hyun Jun
Journal:  In Vivo       Date:  2021 May-Jun       Impact factor: 2.155

3.  EPO protects Müller cell under high glucose state through BDNF/TrkB pathway.

Authors:  Ping Wang; Fei Xia
Journal:  Int J Clin Exp Pathol       Date:  2015-07-01

4.  Overexpression of D-amino acid oxidase prevents retinal neurovascular pathologies in diabetic rats.

Authors:  Haiyan Jiang; He Zhang; Xue Jiang; Shengzhou Wu
Journal:  Diabetologia       Date:  2020-12-14       Impact factor: 10.122

5.  Altered Expression of NF- κ B and SP1 after Exposure to Advanced Glycation End-Products and Effects of Neurotrophic Factors in AGEs Exposed Rat Retinas.

Authors:  Guzel Bikbova; Toshiyuki Oshitari; Takayuki Baba; Shuichi Yamamoto
Journal:  J Diabetes Res       Date:  2015-05-20       Impact factor: 4.011

6.  The correlation between visual acuity outcomes and optical coherence tomography parameters following surgery for diabetic epiretinal membrane and taut posterior hyaloid.

Authors:  Hülya Güngel; Zeynep Kayaarası Öztürker; Sibel Zırtıloğlu; Kadir Eltutar
Journal:  Clin Ophthalmol       Date:  2015-08-18

7.  Therapeutic efficacy of neural stem cells originating from umbilical cord-derived mesenchymal stem cells in diabetic retinopathy.

Authors:  Wei Zhang; Yuexin Wang; Jiahui Kong; Meng Dong; Hongtao Duan; Song Chen
Journal:  Sci Rep       Date:  2017-03-24       Impact factor: 4.379

8.  Assessment of Neurotrophins and Inflammatory Mediators in Vitreous of Patients With Diabetic Retinopathy.

Authors:  Joseph D Boss; Pawan Kumar Singh; Hemang K Pandya; Joaquin Tosi; Chaesik Kim; Asheesh Tewari; Mark S Juzych; Gary W Abrams; Ashok Kumar
Journal:  Invest Ophthalmol Vis Sci       Date:  2017-10-01       Impact factor: 4.799

9.  Neurotrophin-conjugated nanoparticles prevent retina damage induced by oxidative stress.

Authors:  Martina Giannaccini; Alice Usai; Federica Chiellini; Viviana Guadagni; Massimiliano Andreazzoli; Michela Ori; Massimo Pasqualetti; Luciana Dente; Vittoria Raffa
Journal:  Cell Mol Life Sci       Date:  2017-11-02       Impact factor: 9.261

Review 10.  Ocular Complications of Diabetes and Therapeutic Approaches.

Authors:  Victoria J Vieira-Potter; Dimitrios Karamichos; Darren J Lee
Journal:  Biomed Res Int       Date:  2016-03-28       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.